A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension

Clinical trial NCT05564637 · COMPLETED

Trial details

NCT number: NCT05564637
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension Interstitial Lung Disease Healthy Adults

Start date: 2023-03-13
Primary completion: 2024-10-30
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.